Obesity induction in mice requires high-fat diet exposure. While hepatic steatosis develops, progression to inflammation and fibrosis, as in humans, requires prolonged exposure and additional dietary factors. Immunosuppression at room temperature may slow this progression. We evaluated thermoneutrality's effect on MASH development using a fibrosis-inducing MASH (GAN) diet. Mice were fed either MASH or chow diet and housed at room temperature or thermoneutrality. MASH diet groups were sacrificed monthly from 4 to 7 months. Serum markers of hepatic function were analyzed, and liver histology assessed steatosis, inflammation, ballooning (NAS score), and fibrosis via Picrosirius Red staining. MASH diet increased body weight, liver-to-body mass ratio, and hepatic fat, with no difference between housing conditions. Housing temperature had minimal effects on MASH. Serum markers and hepatic fibrosis were similar across groups. NAS score was lower at 4 months in thermoneutral MASH mice but not by 7 months. Thermoneutrality did not significantly impact MASH development. These findings, alongside existing literature, suggest thermoneutral housing does not consistently enhance MASH progression in GAN MASH-fed mice.

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpendo.00401.2024DOI Listing

Publication Analysis

Top Keywords

mash
9
housing temperature
8
room temperature
8
mash development
8
mash diet
8
serum markers
8
markers hepatic
8
nas score
8
diet
6
mice
5

Similar Publications

Cyclophilins have been implicated in the pathophysiology of metabolic dysfunction-associated steatohepatitis (MASH). Pharmacological inhibition of the cyclophilin B isoform has the potential to attenuate liver fibrosis in MASH, but current cyclophilin inhibitors in clinical trials lack isoform selectivity. We previously reported the novel tri-vector small-molecule inhibitor that exhibited improved subtype selectivity by simultaneously engaging three pockets on the surface of cyclophilins.

View Article and Find Full Text PDF

This study evaluated the thermal inactivation kinetic parameters of a Salmonella surrogate Enterococcus faecium (E. faecium) during feed manufacture in a university pilot feed mill setting. A batch of 227 kg mash broiler feed was pelleted after being inoculated with 1,000 mL of nalidixic acid (NaL) resistant E.

View Article and Find Full Text PDF

[Hepatocellular carcinoma (HCC)].

Med Trop Sante Int

December 2024

AP-HP. Centre Université Paris Centre, Groupe hospitalier Cochin Port Royal, Département médical universitaire de Cancérologie et spécialités médico-chirurgicales, Service des maladies du foie, Paris, France; Université Paris Cité, F-75006, Paris, France.

Primary liver cancers are tumors that develop from different liver cells. Hepatocellular carcinoma (HCC), which develops from hepatocytes, accounts for approximately 75-85% of primary liver cancers.HCC is the 6 leading cause of cancer worldwide and the 3 leading cause of cancer-related death.

View Article and Find Full Text PDF

The gut microbiota, a complex microbial ecosystem closely connected to the liver via the portal vein, has emerged as a critical regulator of liver health and disease. Numerous studies have underscored its role in the onset and progression of liver disorders, including alcoholic liver disease, metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction-associated steatohepatitis (MASH), liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). This review provides a comprehensive overview of current insights into the influence of the gut microbiota on HCC progression, particularly its effects on immune cells within the HCC tumor microenvironment (TME).

View Article and Find Full Text PDF

Hormone correction of dysfunctional metabolic gene expression in stem cell-derived liver tissue.

Stem Cell Res Ther

March 2025

Centre for Regenerative Medicine, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh BioQuarter, Edinburgh, EH16 4UU, UK.

The increase in metabolic dysfunction-associated steatotic liver disease (MASLD) and its progression to metabolic dysfunction-associated steatohepatitis (MASH) is a worldwide healthcare challenge. Heterogeneity between men and women in the prevalence and mechanisms of MASLD and MASH is related to differential sex hormone signalling within the liver, and declining hormone levels during aging. In this study we used biochemically characterised pluripotent stem cell derived 3D liver spheres to model the protective effects of testosterone and estrogen signalling on metabolic liver disease 'in the dish'.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!